News from July 2024

July 30, 2024

New Recommendations to Reduce Dementia Risk Worldwide; Untreated High Cholesterol and Vision Loss Linked to Raised Risk

The Commission is authored by 27 dementia experts, including the UW ADRC’s Eric B. Larson, MD, MPH, who is affiliate professor of medicine in the UW School of Medicine, who has now worked on all three Lancet reports that make recommendations for policy makers and individuals to help reduce dementia risk worldwide. Larson gives us context for the new recommendations and shares how UW research has influenced this report.

Read More

Categories: Science Updates, Care & Treatment , Brain Health Awareness


July 22, 2024

My Experience Caring for My Wife Gail and What I Learned About Communication and Alzheimer’s.

I was the caregiver for my late wife Gail over the last five years of her life. I hope to share my experience with other caregivers and relate how changing my way of communicating helped us.

Read More

Categories: Community Stories, Caregiving, Nature


July 15, 2024

Remembering Our Research Colleague, Will Affleck-Asch

It is with great sadness and regret that University of Washington (UW) ADRC announces the passing of our dear colleague Will Affleck-Asch. Will joined the UW ADRC Data, Methods, and Statistics core in 2006, and has since been an instrumental force for implementation of rigorous data management and quality control techniques within our Center. Will was a consistent, passionate, clear voice for reason and logic, always working towards the betterment of the whole, even through his last days with us.

Read More

Categories: Community Stories


July 08, 2024

FDA approves Alzheimer’s drug donanemab

"Donanemab's compelling clinical trial outcome not only confirms that this treatment strategy is effective in treating Alzheimer's disease, but also provides clinicians additional opportunities to tailor the amyloid monoclonal antibody to the individual patient," said MBWC Clinical Trials Director, Michael Rosenbloom, MD

Read More

Categories: Science Updates, New FDA Drug Approvals